Temoporfin-loaded 1-tetradecanol-based thermoresponsive solid lipid nanoparticles for photodynamic therapy.

[1]  A. H. Sathali,et al.  SOLID LIPID NANOPARTICLES: A REVIEW , 2017 .

[2]  K. Araki,et al.  Nanotechnology, Light and Chemical Action: an Effective Combination to Kill Cancer Cells , 2015 .

[3]  Michael R Hamblin,et al.  Drug Carrier for Photodynamic Cancer Therapy , 2015, International journal of molecular sciences.

[4]  Michael R Hamblin,et al.  Photodynamic therapy: one step ahead with self-assembled nanoparticles. , 2014, Journal of biomedical nanotechnology.

[5]  S. Mordon,et al.  Photodynamic therapy of malignant brain tumours: a complementary approach to conventional therapies. , 2014, Cancer treatment reviews.

[6]  W. Rizzo.  Fatty aldehyde and fatty alcohol metabolism: review and importance for epidermal structure and function. , 2014, Biochimica et biophysica acta.

[7]  P. Elias,et al.  The important role of lipids in the epidermis and their role in the formation and maintenance of the cutaneous barrier. , 2014, Biochimica et biophysica acta.

[8]  P. Štěpánek,et al.  Self-association of bee propolis: effects on pharmaceutical applications , 2014, Journal of Pharmaceutical Investigation.

[9]  M. Barberi-Heyob,et al.  Preparation and characterization of mTHPC-loaded solid lipid nanoparticles for photodynamic therapy. , 2014, Journal of photochemistry and photobiology. B, Biology.

[10]  A. Habtemariam,et al.  Light Harvesting and Photoemission by Nanoparticles for Photodynamic Therapy , 2014 .

[11]  F. Guillemin,et al.  Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfin): comparison of treatment efficacy and distribution characteristics in vivo , 2013, International journal of nanomedicine.

[12]  M. Edirisinghe,et al.  Preparation of solid lipid nanoparticles containing active compound by electrohydrodynamic spraying , 2013, Food Research International.

[13]  E. Olanipekun,et al.  POLYCYCLIC AROMATIC HYDROCARBONS (PAHs) AND POLYCHLORINATED BIPHENYLS (PCBs) IN SOILS OF AGBABU, NIGERIA , 2013 .

[14]  Ick Chan Kwon,et al.  Nanophotosensitizers toward advanced photodynamic therapy of Cancer. , 2013, Cancer letters.

[15]  M. Kuroki,et al.  Tumor-targeted photodynamic therapy. , 2013, Anticancer research.

[16]  Kishan Veerabrahma,et al.  Preparation, Characterization and Evaluation of Quetiapine Fumarate Solid Lipid Nanoparticles to Improve the Oral Bioavailability , 2013, Journal of pharmaceutics.

[17]  Norio Murase,et al.  Nanomaterials formulations for photothermal and photodynamic therapy of cancer , 2013 .

[18]  R. Chandra,et al.  Poly (ethylene)-glycol conjugated solid lipid nanoparticles of noscapine improve biological half-life, brain delivery and efficacy in glioblastoma cells. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[19]  P. Chattopadhyay,et al.  Development of solid lipid nanoparticles (SLNs) of lopinavir using hot self nano-emulsification (SNE) technique. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[20]  Ajay Kumar,et al.  Enhanced anticancer potential of encapsulated solid lipid nanoparticles of TPD: a novel triterpenediol from Boswellia serrata. , 2013, Molecular pharmaceutics.

[21]  P. Kasák,et al.  Development of a new LDL-based transport system for hydrophobic/amphiphilic drug delivery to cancer cells. , 2012, International journal of pharmaceutics.

[22]  D. Maria,et al.  Drug-targeting in combined cancer chemotherapy: tumor growth inhibition in mice by association of paclitaxel and etoposide with a cholesterol-rich nanoemulsion , 2012, Cellular Oncology.

[23]  C. Puglia,et al.  Lipid nanoparticles for brain targeting I. Formulation optimization. , 2011, International journal of pharmaceutics.

[24]  C. Moore,et al.  Photodynamic therapy for prostate cancer—an emerging approach for organ‐confined disease , 2011, Lasers in surgery and medicine.

[25]  Philip Chi Lip Kwok,et al.  Production methods for nanodrug particles using the bottom-up approach. , 2011, Advanced drug delivery reviews.

[26]  Jian Zhang,et al.  Physical and chemical stability of drug nanoparticles. , 2011, Advanced drug delivery reviews.

[27]  W. Gallagher,et al.  Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy , 2009, Photochemistry and photobiology.

[28]  S. Mukherjee,et al.  Solid Lipid Nanoparticles: A Modern Formulation Approach in Drug Delivery System , 2009, Indian journal of pharmaceutical sciences.

[29]  M. Waring.  Defining optimum lipophilicity and molecular weight ranges for drug candidates-Molecular weight dependent lower logD limits based on permeability. , 2009, Bioorganic & medicinal chemistry letters.

[30]  T. Bříza,et al.  Glycol porphyrin derivatives as potent photodynamic inducers of apoptosis in tumor cells. , 2008, Journal of medicinal chemistry.

[31]  P. Gramatica,et al.  Comparison between 5,10,15,20-tetraaryl- and 5,15-diarylporphyrins as photosensitizers: synthesis, photodynamic activity, and quantitative structure-activity relationship modeling. , 2006, Journal of medicinal chemistry.

[32]  L. Rizza,et al.  Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. , 2005, International journal of pharmaceutics.

[33]  François Guillemin,et al.  Investigation of Foscan interactions with plasma proteins. , 2005, Biochimica et biophysica acta.

[34]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[35]  R. Müller,et al.  Solid lipid nanoparticles for parenteral drug delivery. , 2004, Advanced drug delivery reviews.

[36]  Dennis E Discher,et al.  Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[37]  D. Vernon,et al.  Photodynamic therapy effect of m-THPC (Foscan®) in vivo: correlation with pharmacokinetics , 2003, British Journal of Cancer.

[38]  K. Ulbrich,et al.  Synthetic macromolecular drug carriers: biodistribution of poly[(N-2-hydroxypropyl)methacrylamide] copolymers and their accumulation in solid rat tumors. , 2001, PDA journal of pharmaceutical science and technology.

[39]  W Mehnert,et al.  Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[40]  R. Whelpton,et al.  Binding of temoporfin to the lipoprotein fractions of human serum. , 1995, British journal of clinical pharmacology.

[41]  R. Lawson.  Implications of surface temperatures in the diagnosis of breast cancer. , 1956, Canadian Medical Association journal.

[42]  A. Zimmer,et al.  Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[43]  H. Maeda,et al.  The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. , 2013, Advanced drug delivery reviews.

[44]  Panakanti Pavan Kumar.  Atorvastatin Loaded Solidlipid Nanoparticles: Formulation, Optimization, and in - vitro Characterization , 2012 .

[45]  T. Bříza,et al.  Combination of two chromophores: synthesis and PDT application of porphyrin-pentamethinium conjugate. , 2012, Bioorganic & medicinal chemistry letters.

[46]  Xinyi Gu.  A novel approach to formulation of anticancer drugs in nanoparticles , 2008 .

[47]  Luba Vasiluk.  Development of an in vitro system to assess the oral bioavailability of hydrophobic contaminants , 2006 .

[48]  P. Haycock,et al.  Fine structure of 5,10,15,20-tetrakis(m-hydroxyphenyl)chlorin (m-THPC): a 1H, 13C and 15N NMR study , 1994 .

[49]  Bender Ki,et al.  Dependence of the absorption through the human oral mucosa of antihistaminic (H1) preparations on their physicochemical properties , 1988 .

[50]  Xinsheng Peng,et al.  International Journal of Nanomedicine Dovepress Development and Optimization of Solid Lipid Nanoparticle Formulation for Ophthalmic Delivery of Chloramphenicol Using a Box-behnken Design , 2022 .